• OPEN AN ACCOUNT
Indian Indices
Nifty
24,946.50 227.90
(0.92%)
Sensex
81,796.15 0.00
( 0.00%)
Bank Nifty
55,944.90 417.55
( 0.75%)
Nifty IT
39,073.05 603.80
( 1.57%)
Global Indices
Nasdaq
42,540.48 321.68
(0.76%)
Dow Jones
6,054.14 56.17
(0.94%)
Hang Seng
38,275.58 441.33
(1.17%)
Nikkei 225
8,875.22 24.59
(0.28%)
Forex
USD-INR
85.72 0.17
(0.19%)
EUR-INR
98.97 0.08
(0.08%)
GBP-INR
116.32 0.08
(0.07%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Sanofi Consumer Healthcare India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
544250
INE0UOS01011
118.5511281
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SANOFICONR
62.42
11699.56
EPS(TTM)
Face Value()
Div & Yield %
81.39
10
1.08
 

Forbes & Company Ltd - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2025.
Apr 23,2025
Forbes & Company Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31 2025 along with the Auditors Report by Statutory Auditors of the Company